INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $971,000 | -96.5% | 6,503 | -94.3% | 0.01% | -95.2% |
| Q2 2015 | $27,777,000 | +12412.2% | 115,076 | +14503.6% | 0.15% | +14500.0% |
| Q1 2015 | $222,000 | -97.9% | 788 | -98.9% | 0.00% | -98.6% |
| Q4 2014 | $10,775,000 | -22.9% | 69,073 | +17.0% | 0.07% | +23.2% |
| Q3 2014 | $13,969,000 | +85.2% | 59,018 | +85.2% | 0.06% | +43.6% |
| Q2 2014 | $7,542,000 | -28.5% | 31,874 | -0.4% | 0.04% | -13.3% |
| Q1 2014 | $10,553,000 | -36.3% | 32,000 | -41.9% | 0.04% | -44.4% |
| Q4 2013 | $16,567,000 | +2347.1% | 55,061 | +264.6% | 0.08% | +2600.0% |
| Q2 2013 | $677,000 | – | 15,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |